| 摘要 |
The treatment and/or prophylactic drugs of post-traumatic stress disorder (PTSD) containing compounds(EP, agonists), which activate EP, receptor that is subtype of prostaglandin E2 receptor, as an active ingredient. EP, agonists such as (13E)-(11 .alpha. , 15S, 17S)-2, 5-ethano-6, 9-dioxo-11 , 15-dihydro-17, 20-dimethylprosta-13-enoic acid, PGE1, or PGE2, etc. are usef ul for the treatment of post-traumatic stress disorder (PTSD). |
